Christopher A. Newton

2.4k total citations
30 papers, 1.6k citations indexed

About

Christopher A. Newton is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Christopher A. Newton has authored 30 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Endocrinology, Diabetes and Metabolism, 8 papers in Genetics and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Christopher A. Newton's work include Diabetes Management and Research (18 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (18 papers) and Diabetes and associated disorders (7 papers). Christopher A. Newton is often cited by papers focused on Diabetes Management and Research (18 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (18 papers) and Diabetes and associated disorders (7 papers). Christopher A. Newton collaborates with scholars based in United States, Denmark and Canada. Christopher A. Newton's co-authors include Philip Raskin, Guillermo E. Umpierrez, Dawn Smiley, Almond J. Drake, Robert J. Tanenberg, Limin Peng, Francisco J. Pasquel, Sol Jacobs, David Rafael Abreu Reyes and Farnoosh Farrokhi and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Diabetes.

In The Last Decade

Christopher A. Newton

29 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher A. Newton United States	21	1.3k	459	270	211	185	30	1.6k
Dara P. Schuster United States	22	573 0.4×	254 0.6×	336 1.2×	159 0.8×	265 1.4×	39	1.3k
J. Fowelin Sweden	15	990 0.8×	163 0.4×	198 0.7×	225 1.1×	483 2.6×	23	1.4k
R. Ravi Shankar United States	18	573 0.4×	140 0.3×	164 0.6×	171 0.8×	137 0.7×	43	1.1k
I. F. Casson United Kingdom	14	589 0.5×	142 0.3×	291 1.1×	158 0.7×	120 0.6×	35	1.4k
Tarik Elhadd United Kingdom	20	575 0.5×	98 0.2×	131 0.5×	108 0.5×	375 2.0×	65	1.2k
Lorenza Santi Italy	14	625 0.5×	66 0.1×	187 0.7×	215 1.0×	177 1.0×	23	1.3k
Mads Axelsen Denmark	7	968 0.8×	81 0.2×	396 1.5×	523 2.5×	208 1.1×	14	1.7k
Gerard Boran Ireland	15	469 0.4×	66 0.1×	151 0.6×	174 0.8×	96 0.5×	57	1.2k
Wayne Weng United States	19	789 0.6×	134 0.3×	226 0.8×	197 0.9×	110 0.6×	34	1.2k
Jung‐Fu Chen Taiwan	19	546 0.4×	71 0.2×	296 1.1×	152 0.7×	180 1.0×	52	1.2k

Countries citing papers authored by Christopher A. Newton

Since Specialization

Citations

This map shows the geographic impact of Christopher A. Newton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher A. Newton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher A. Newton more than expected).

Fields of papers citing papers by Christopher A. Newton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher A. Newton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher A. Newton. The network helps show where Christopher A. Newton may publish in the future.

Co-authorship network of co-authors of Christopher A. Newton

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher A. Newton. A scholar is included among the top collaborators of Christopher A. Newton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher A. Newton. Christopher A. Newton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Consitt, Leslie A., Timothy R. Koves, Deborah M. Muoio, et al.. (2016). Plasma acylcarnitines during insulin stimulation in humans are reflective of age-related metabolic dysfunction. Biochemical and Biophysical Research Communications. 479(4). 868–874. 17 indexed citations

Vellanki, Priyathama, Francisco J. Pasquel, Dawn Smiley, et al.. (2015). Randomized Controlled Trial of Insulin Supplementation for Correction of Bedtime Hyperglycemia in Hospitalized Patients With Type 2 Diabetes. Diabetes Care. 38(4). 568–574. 19 indexed citations

Smiley, Dawn, Guillermo E. Umpierrez, Kathie L. Hermayer, et al.. (2013). Differences in inpatient glycemic control and response to subcutaneous insulin therapy between medicine and surgery patients with type 2 diabetes. Journal of Diabetes and its Complications. 27(6). 637–641. 9 indexed citations

Farrokhi, Farnoosh, Chandra Prakash, Dawn Smiley, et al.. (2013). Glucose Variability is an Independent Predictor of Mortality in Hospitalized Patients Treated with Total Parenteral Nutrition. Endocrine Practice. 20(1). 41–45. 31 indexed citations

Newton, Christopher A., Shahid Adeel, Alexandra L. Migdal, et al.. (2013). Prevalence, Quality of Care, and Complications in Long Term Care Residents With Diabetes: A Multicenter Observational Study. Journal of the American Medical Directors Association. 14(11). 842–846. 45 indexed citations

Gosmanov, Aidar R., et al.. (2012). Vascular effects of intravenous intralipid and dextrose infusions in obese subjects. Metabolism. 61(10). 1370–1376. 20 indexed citations

Umpierrez, Guillermo E., Vivian Zhao, Dawn Smiley, et al.. (2012). A double-blind, randomized clinical trial comparing soybean oil–based versus olive oil–based lipid emulsions in adult medical–surgical intensive care unit patients requiring parenteral nutrition*. Critical Care Medicine. 40(6). 1792–1798. 52 indexed citations

Farrokhi, Farnoosh, Chandra Prakash, Limin Peng, et al.. (2012). Risk Factors for Inpatient Hypoglycemia during Subcutaneous Insulin Therapy in Non-Critically Ill Patients with Type 2 Diabetes. Journal of Diabetes Science and Technology. 6(5). 1022–1029. 55 indexed citations

Newton, Christopher A., Dawn Smiley, Bruce W. Bode, et al.. (2010). A comparison study of continuous insulin infusion protocols in the medical intensive care unit: Computer‐guided vs. standard column‐based algorithms. Journal of Hospital Medicine. 5(8). 432–437. 58 indexed citations

10.

Johnson, Susan L., Laura N. McEwen, Christopher A. Newton, et al.. (2010). The impact of continuous subcutaneous insulin infusion and multiple daily injections of insulin on glucose variability in older adults with type 2 diabetes. Journal of Diabetes and its Complications. 25(4). 211–215. 22 indexed citations

11.

Tanenberg, Robert J., et al.. (2009). Primary Care Fellowship in Diabetes: An Innovative Program in Postgraduate Diabetes Education. Teaching and Learning in Medicine. 21(4). 334–343. 4 indexed citations

12.

Tanenberg, Robert J., Christopher A. Newton, & Almond J. Drake. (2009). Confirmation of Hypoglycemia in the “Dead-In-Bed” Syndrome, as Captured by a Retrospective Continuous Glucose Monitoring System. Endocrine Practice. 16(2). 244–248. 163 indexed citations

13.

Toschlog, Eric A., Christopher A. Newton, Mark A. Newell, et al.. (2007). Morbidity Reduction in Critically Ill Trauma Patients Through use of a Computerized Insulin Infusion Protocol: A Preliminary Study. The Journal of Trauma: Injury, Infection, and Critical Care. 62(6). 1370–1376. 27 indexed citations

14.

Newton, Christopher A., et al.. (2007). Acute Myocardial Infarction Attributable to Adrenergic Crises in a Patient with Pheochromocytoma and Neurofibromatosis 1. Endocrine Practice. 13(3). 269–273. 11 indexed citations

15.

Newton, Christopher A. & Guillermo E. Umpierrez. (2007). Obtaining Positive Outcomes with Insulin Therapy in Hospitalized Patients. 2. S47–S56. 1 indexed citations

16.

Newton, Christopher A., et al.. (2006). Financial Implications of Glycemic Control: Results of An Inpatient Diabetes Management Program. Endocrine Practice. 12. 43–48. 77 indexed citations

17.

Newton, Christopher A. & Philip Raskin. (2004). Diabetic Ketoacidosis in Type 1 and Type 2 Diabetes Mellitus. Archives of Internal Medicine. 164(17). 1925–1925. 177 indexed citations

18.

Newton, Christopher A., et al.. (2002). Calcium and Beta Receptor Antagonist Overdose: A Review and Update of Pharmacological Principles and Management. Seminars in Respiratory and Critical Care Medicine. 23(1). 19–26. 34 indexed citations

19.

Newton, Christopher A. & Philip Raskin. (2002). Blood pressure control—Effects on diabetic nephropathy progression: How low does blood pressure have to be?. Current Diabetes Reports. 2(6). 530–538. 4 indexed citations

20.

Newton, Christopher A., et al.. (1996). Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study. Fertility and Sterility. 65(6). 1253–1255. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact